EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants

Sneha Vishwanath, George William Carnell, Martina Billmeier, Luis Ohlendorf, Patrick Neckermann, Benedikt Asbach, Charlotte George, Maria Suau Sans, Andrew Chan, Joey Olivier, Angalee Nadesalingam, Sebastian Einhauser und 14 weitere

npj Vaccines · 09.09.2024 · 9 (1)

DOI: 10.1038/s41541-024-00950-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift npj Vaccines, online erschienen am 09.09.2024. Verfasst von Sneha Vishwanath und 25 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, United Kingdom. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovate UK.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Updates of SARS-CoV-2 vaccines are required to generate immunity in the population against constantly evolving SARS-CoV-2 variants of concerns (VOCs). Here we describe three novel in-silico designed spike-based antigens capable of inducing neutralising antibodies across a spectrum of SARS-CoV-2 VOCs. Three sets of antigens utilising pre-Delta (T2_32), and post-Gamma sequence data (T2_35 and T2_36) were designed. T2_32 elicited superior neutralising responses against VOCs compared to the Wuhan-1 spike antigen in DNA prime-boost immunisation regime in guinea pigs. Heterologous boosting with the attenuated poxvirus - Modified vaccinia Ankara expressing T2_32 induced broader neutralising immune responses in all primed animals. T2_32, T2_35 and T2_36 elicited broader neutralising capacity compared to the Omicron BA.1 spike antigen administered by mRNA immunisation in mice. These findings demonstrate the utility of structure-informed computationally derived modifications of spike-based antigens for inducing broad immune responses covering more than 2 years of evolved SARS-CoV-2 variants.

Autor:innen und Institutionen

  • Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, United Kingdom.
  • Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
  • Viral Pseudotype Unit, Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Chatham, United Kingdom.
  • MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
  • ProBioGenAG, Berlin, Germany.
  • Ethris GmbH, Semmelweisstraße 3, 82152, Planegg, Germany.

Förderung

  • Innovate UK

Zitieren

APA

Vishwanath, S., Carnell, G. W., Billmeier, M., Ohlendorf, L., Neckermann, P., Asbach, B., George, C., Sans, M. S., Chan, A., Olivier, J., Nadesalingam, A., Einhauser, S., Temperton, N., Cantoni, D., Grove, J., Jordan, I., Sandig, V., Tonks, P., Geiger, J., …, & Heeney, J. L. (2024). Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants. npj Vaccines, 9(1). https://doi.org/10.1038/s41541-024-00950-9

Vancouver

Vishwanath S, Carnell GW, Billmeier M, Ohlendorf L, Neckermann P, Asbach B, et al. Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants. npj Vaccines. 2024;9(1). doi:10.1038/s41541-024-00950-9

BibTeX
@article{Vishwanath2024,
  author = {Vishwanath, Sneha and Carnell, George William and Billmeier, Martina and Ohlendorf, Luis and Neckermann, Patrick and Asbach, Benedikt and George, Charlotte and Sans, Maria Suau and Chan, Andrew and Olivier, Joey and Nadesalingam, Angalee and Einhauser, Sebastian and Temperton, Nigel and Cantoni, Diego and Grove, Joe and Jordan, Ingo and Sandig, Volker and Tonks, Paul and Geiger, Johannes and Dohmen, Christian and Mummert, Verena and Samuel, Anne Rosalind and Plank, Christian and Kinsley, Rebecca and Wagner, Ralf and Heeney, Jonathan Luke},
  title = {Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants},
  journal = {npj Vaccines},
  year = {2024},
  volume = {9},
  number = {1},
  doi = {10.1038/s41541-024-00950-9}
}
Kostenlos starten →